{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:58:57Z","timestamp":1782997137219,"version":"3.54.5"},"reference-count":112,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2017,9,2]]},"DOI":"10.1080\/14740338.2017.1354983","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T10:17:58Z","timestamp":1499854678000},"page":"1039-1049","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":27,"title":["Safety of available and emerging drug therapies for hyperhidrosis"],"prefix":"10.1080","volume":"16","author":[{"given":"Christine","family":"Hosp","sequence":"first","affiliation":[{"name":",","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Hamm","sequence":"additional","affiliation":[{"name":",","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,7,16]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-016-1697-9"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-016-0148-z"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S53119"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2002.119507"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1464"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/308650"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2014.06.004"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000060693"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2340\/0001555558461465","article-title":"Axillary hyperhidrosis: local treatment with aluminum chloride hexahydrate 25% in absolute ethanol","volume":"58","author":"Brandrup F","year":"1978","unstructured":"Brandrup F, Larsen PO. Axillary hyperhidrosis: local treatment with aluminum chloride hexahydrate 25% in absolute ethanol. Acta Derm Venereol. 1978;58:461\u2013465.","journal-title":"Acta Derm Venereol"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6139.773-a"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.55.650.868"},{"key":"e_1_3_3_14_1","first-page":"303","article-title":"Die Behandlung der Hyperhidrosis axillaris mit Aluminiumchloridl\u00f6sungen","volume":"20","author":"Hilbrans JH","year":"1994","unstructured":"Hilbrans JH, Holzle E. Die Behandlung der Hyperhidrosis axillaris mit Aluminiumchloridl\u00f6sungen. Akt Dermatol. 1994;20:303\u2013308.","journal-title":"Akt Dermatol"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6258.150-a"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2340\/000155555241260","article-title":"Studies on topical antiperspirant control of axillary hyperhidrosis","volume":"55","author":"Shelley WB","year":"1975","unstructured":"Shelley WB, Hurley HJ Jr. Studies on topical antiperspirant control of axillary hyperhidrosis. Acta Dermato Venereol. 1975;55:241\u2013260.","journal-title":"Acta Dermato Venereol"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042533313505511"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jat.1641"},{"key":"e_1_3_3_19_1","unstructured":"Aluminium-containing antiperspirants contribute to aluminium intake. BfR. 2014. [cited 2017 Feb 15]. Available from: http:\/\/wwwbfrbundde\/cm\/349\/aluminium-containing-antiperspirants-contribute-to-aluminium-intakepdf"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2012.02.013"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-6915(00)00118-6"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2013.07.003"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30393"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-200110000-00002"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.morpho.2016.02.001"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/jat.1793"},{"key":"e_1_3_3_27_1","first-page":"871","article-title":"[The use of deodorants\/antiperspirants does not constitute a risk factor for breast cancer]","volume":"95","author":"Namer M","year":"2008","unstructured":"Namer M, Luporsi E, Gligorov J, et al. [The use of deodorants\/antiperspirants does not constitute a risk factor for breast cancer]. Bull Cancer. 2008;95:871\u2013880. French.","journal-title":"Bull Cancer"},{"key":"e_1_3_3_28_1","first-page":"478","article-title":"Antiperspirant use as a risk factor for breast cancer in Iraq","volume":"12","author":"Fakri S","year":"2006","unstructured":"Fakri S, Al-Azzawi A, Al-Tawil N. Antiperspirant use as a risk factor for breast cancer in Iraq. East Mediterr Health J. 2006;12:478\u2013482.","journal-title":"East Mediterr Health J"},{"key":"e_1_3_3_29_1","first-page":"27","article-title":"Accumulation of aluminum in cancers of the liver, stomach, duodenum and mammary glands of rats","volume":"8","author":"Ogoshi K","year":"1994","unstructured":"Ogoshi K, Yanagi S, Moriyama T, et al. Accumulation of aluminum in cancers of the liver, stomach, duodenum and mammary glands of rats. J Trac Elem Electrolytes Health Dis. 1994;8:27\u201331.","journal-title":"J Trac Elem Electrolytes Health Dis"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1191\/0748233702th157oa"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197601222940402"},{"key":"e_1_3_3_32_1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0749-0690(18)30721-3","article-title":"Dialysis dementia","volume":"4","author":"Mach JR","year":"1988","unstructured":"Mach JR Jr., Korchik WP, Mahowald MW. Dialysis dementia. Clin Geriatr Med. 1988;4:853\u2013867.","journal-title":"Clin Geriatr Med"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-016-0342-y"},{"key":"e_1_3_3_34_1","unstructured":"No risk of Alzheimer\u2019s disease from aluminium in consumer products. BfR 2005. Updated* BfR Health Assessment No 033\/2007. [cited 2017 Feb 15]. Available from: http:\/\/www.bfr.bund.de\/cm\/349\/no_risk_of_alzheimers_disease_from_aluminium_in_consumer_products.pdf"},{"key":"e_1_3_3_35_1","first-page":"34273","article-title":"Food and Drug Administration, HHS. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule","volume":"68","year":"2003","unstructured":"Food and Drug Administration, HHS. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule. Federal Regist. 2003;68:34273\u201334293.","journal-title":"Federal Regist"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2015.09.006"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08476.x"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12518"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-200295070-00019"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2003.44.4.579"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13745"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07336.x"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12857"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12320"},{"key":"e_1_3_3_45_1","unstructured":"The use of topical oxybutynin 10% for treating primary focal hyperhidrosis-axillary palmar and plantar. [cited 2017 Feb 15]. Available from: https:\/\/clinicaltrialsgov\/ct2\/show\/NCT02973659?term=topical+oxybutynin+hyperhidrosis&rank=1"},{"key":"e_1_3_3_46_1","unstructured":"A pilot study exploring the efficacy and safety of topical oxybutynin 3% gel for primary focal hyperhidrosis in adolescents and young adults. [cited 2017 Feb 15]. Available from: https:\/\/clinicaltrialsgov\/ct2\/show\/NCT02633371?term=topical+oxybutynin+hyperhidrosis&rank=2"},{"key":"e_1_3_3_47_1","unstructured":"Safety and efficacy of botulinum toxin type A topical gel for primary axillary hyperhidrosis. [cited 2017 Feb 15]. Available from: https:\/\/clinicaltrialsgov\/ct2\/show\/NCT02565732?term=topical+hyperhidrosis&rank=10"},{"key":"e_1_3_3_48_1","first-page":"191","article-title":"Anticholinergics and central nervous system effects: are we confused?","volume":"9","author":"Staskin DR","year":"2007","unstructured":"Staskin DR, Zoltan E. Anticholinergics and central nervous system effects: are we confused? Rev Urol. 2007;9:191\u2013196.","journal-title":"Rev Urol"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04708.x"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0353.2004.04765.x"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14081"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502900507"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1967.tb11406.x"},{"key":"e_1_3_3_54_1","first-page":"4","article-title":"Hyperhidrosis-how to help our patients","volume":"19","author":"Halford JHN","year":"2013","unstructured":"Halford JHN. Hyperhidrosis-how to help our patients. Dermatol Pract. 2013;19:4\u20139.","journal-title":"Dermatol Pract"},{"key":"e_1_3_3_55_1","unstructured":"Policy statement - Management of hyperhidrosis. Dorset Clinical Commissioning Group. [cited 2017 Feb 18]. Available from: http:\/\/wwwdorsetccgnhsuk\/Downloads\/aboutus\/medicines-management\/Other%20Guidelines\/Policy%20and%20Pathway%20for%20Management%20of%20hyperhidrosispdf"},{"key":"e_1_3_3_56_1","unstructured":"Hyperhidrosis:oralglycopyrronium bromide. National Institute for Health and Care Excellence. [cited 2017 Mar 17]. Available from: https:\/\/www.nice.org.uk\/guidance\/esuom16\/resources\/hyperhidrosis-oral-glycopyrronium-bromide-pdf-54116458944469189"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07884.x"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.2012.25.1.28"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.01.023"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.2013.26.1.89"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.02.012"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12236"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14876"},{"key":"e_1_3_3_64_1","unstructured":"Hyperhidrosis Support Group. [cited 2017 Mar 17]. Available from: http:\/\/www.hyperhidrosisuk.org\/treatment-options\/medications.html"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13973"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2011.12.039"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2014(02)05"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12385"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1679-45082014AO2841"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2011.06.007"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12729"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-014-0264-8"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ramb.2012.11.002"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20143272"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962011000300005"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2013.12.024"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2008.12"},{"key":"e_1_3_3_78_1","unstructured":"Package insert of Sormodren\u00ae. [cited 2017 Mar 18]. Available from: https:\/\/wwwfachinfode\/pdf\/001925 (secured access for physicians)"},{"key":"e_1_3_3_79_1","volume-title":"Therapeutic Drugs","author":"Dollery C","year":"1999","unstructured":"Dollery C, editor. Therapeutic Drugs. 2nd ed. Vol. 1&2, Edinburgh: Churchill Livingstone; 1999.","edition":"2"},{"key":"e_1_3_3_80_1","unstructured":"Anticholinergic medications. DermNet Zew Zealand. [cited 2016 Mar 17]. Available from: https:\/\/www.dermnetnz.org\/topics\/anticholinergic-medications"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1159\/000371581"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199104253241707"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2015.08.001"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.3.301"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7313.596"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.6.731"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1571214"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S65603"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23254"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2003.05620.x"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2006.32331.x"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200204000-00027"},{"key":"e_1_3_3_93_1","doi-asserted-by":"crossref","first-page":"686329","DOI":"10.1155\/2013\/686329","article-title":"Efficacy of onabotulinum toxin A (Botox) versus abobotulinum toxin A (Dysport) using a conversion factor (1: 2.5) in treatment of primary palmar hyperhidrosis","volume":"2013","author":"El Kahky HM","year":"2013","unstructured":"El Kahky HM, Diab HM, Aly DG, et al. Efficacy of onabotulinum toxin A (Botox) versus abobotulinum toxin A (Dysport) using a conversion factor (1: 2.5) in treatment of primary palmar hyperhidrosis. Dermatol Res Pract. 2013;2013:686329.","journal-title":"Dermatol Res Pract"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-010-0372-0"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-013-1074-1"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2003.11.005"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-002-0929-4"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2010.04.009"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6615-2"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10495"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20290"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12625"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24304"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e31826248b8"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.2.226"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.49101.x"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000178"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.104661"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-0101(03)00196-X"},{"key":"e_1_3_3_110_1","first-page":"1183","article-title":"Botulinum toxin type A in pregnancy","volume":"59","author":"Tan M","year":"2013","unstructured":"Tan M, Kim E, Koren G, et al. Botulinum toxin type A in pregnancy. Can Fam Physician. 2013;59:1183\u20131184.","journal-title":"Can Fam Physician"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-107-26604"},{"key":"e_1_3_3_112_1","unstructured":"Package insert of Botox\u00ae. [cited 2017 Mar 10]. Available from: http:\/\/www.allergan.com\/assets\/pdf\/botox_pi.pdf"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3920"},{"key":"e_1_3_3_114_1","unstructured":"Package insert of Botox\u00ae. [cited 2017 Mar 10]. Available from: https:\/\/www.fachinfo.de\/suche\/fi\/020408 (secured access for physicians)"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2017.1354983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:56:35Z","timestamp":1770371795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2017.1354983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,16]]},"references-count":112,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9,2]]}},"alternative-id":["10.1080\/14740338.2017.1354983"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2017.1354983","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-04-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}